Biotech · Private company
Actelion
Track this companyFree. Adds Actelion to your Dealase workspace and tells you when its record changes.
Clinical trials253 recruiting or active
Pipeline programs35From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline35
- ACT-293987Phase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- BosentanPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- CadazolidPhase 3 · Clostridium Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- FDC macitentan/tadalafilPhase 3 · Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)ClinicalTrials.gov · fetched Nov 12, 2026
- i.v. selexipagPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- MacitentanPhase 3 · Chronic Thromboembolic Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- MacitentanPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Macitentan 10 mgPhase 3 · Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)ClinicalTrials.gov · fetched Nov 12, 2026
- Macitentan 10 mgPhase 3 · Congenital Heart DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Macitentan 10 mgPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Macitentan 37.5 mgPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Macitentan 75 mgPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- oral selexipag (Uptravi)Phase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- PonesimodPhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- SelexipagPhase 3 · Hypertension, PulmonaryClinicalTrials.gov · fetched Nov 12, 2026
- SelexipagPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- SOC: Phosphodiesterase type 5 (PDE-5) inhibitorPhase 3 · Hypertension, PulmonaryClinicalTrials.gov · fetched Nov 12, 2026
- SOC: Soluble guanylate cyclase stimulatorPhase 3 · Hypertension, PulmonaryClinicalTrials.gov · fetched Nov 12, 2026
- Standard-of-carePhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- TadalafilPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Tadalafil 40 mgPhase 3 · Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)ClinicalTrials.gov · fetched Nov 12, 2026
- teriflunomidePhase 3 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin capsulePhase 3 · Clostridium Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Vancomycin solutionPhase 3 · Clostridium Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- ACT-128800 Dose 1Phase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- ACT-128800 Dose 2Phase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- ACT-128800 Dose 3Phase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- MacitentanPhase 2 · Heart Failure With Preserved Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- Macitentan 10mgPhase 2 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Ponesimod 10 mgPhase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Ponesimod 20 mgPhase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Ponesimod 40 mgPhase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- selexipag (Uptravi)Phase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- MacitentanPortopulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Opsumit (macitentan)Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary HypertensionPHASE3 · TERMINATED · started Jul 7, 2020ClinicalTrials.gov NCT04271475 · fetched Nov 12, 2026
- Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial HypertensionPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 30, 2020ClinicalTrials.gov NCT04273945 · fetched Nov 12, 2026
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial HypertensionPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 16, 2020ClinicalTrials.gov NCT04175600 · fetched Nov 12, 2026
- Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)PHASE3 · COMPLETED · started Jul 29, 2019ClinicalTrials.gov NCT03904693 · fetched Nov 12, 2026
- Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis FungoidesPHASE2 · WITHDRAWN · started Aug 1, 2018ClinicalTrials.gov NCT03288818 · fetched Nov 12, 2026
- A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial HypertensionPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 23, 2018ClinicalTrials.gov NCT03492177 · fetched Nov 12, 2026
- Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial HypertensionPHASE3 · COMPLETED · started Dec 4, 2017ClinicalTrials.gov NCT03187678 · fetched Nov 12, 2026
- Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.PHASE4 · COMPLETED · started Nov 8, 2017ClinicalTrials.gov NCT03078907 · fetched Nov 12, 2026
- A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)PHASE3 · COMPLETED · started Oct 24, 2017ClinicalTrials.gov NCT02932410 · fetched Nov 12, 2026
- Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated SubjectsPHASE3 · COMPLETED · started Aug 14, 2017ClinicalTrials.gov NCT03153137 · fetched Nov 12, 2026
- A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular DiseasePHASE2 · COMPLETED · started Jul 11, 2017ClinicalTrials.gov NCT03153111 · fetched Nov 12, 2026
- Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple SclerosisPHASE3 · COMPLETED · started Jul 5, 2017ClinicalTrials.gov NCT03232073 · fetched Nov 12, 2026
- Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)PHASE2_PHASE3 · TERMINATED · started Apr 14, 2017ClinicalTrials.gov NCT03105479 · fetched Nov 12, 2026
- The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial HypertensionPHASE3 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02558231 · fetched Nov 12, 2026
- Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device ImplantationPHASE2 · COMPLETED · started Mar 28, 2016ClinicalTrials.gov NCT02554903 · fetched Nov 12, 2026
- PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical TrialPHASE4 · COMPLETED · started Jun 23, 2015ClinicalTrials.gov NCT02382016 · fetched Nov 12, 2026
- Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisPHASE3 · COMPLETED · started Jun 4, 2015ClinicalTrials.gov NCT02425644 · fetched Nov 12, 2026
- REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtensionPHASE4 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02310672 · fetched Nov 12, 2026
- OPsumit USers RegistryCOMPLETED · started Apr 30, 2014ClinicalTrials.gov NCT02126943 · fetched Nov 12, 2026
- FUTURE 3 Study ExtensionPHASE3 · COMPLETED · started Mar 8, 2011ClinicalTrials.gov NCT01338415 · fetched Nov 12, 2026
- ACT-293987 in Pulmonary Arterial HypertensionPHASE3 · COMPLETED · started Jul 7, 2010ClinicalTrials.gov NCT01112306 · fetched Nov 12, 2026
- Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple SclerosisPHASE2 · COMPLETED · started May 12, 2010ClinicalTrials.gov NCT01093326 · fetched Nov 12, 2026
- Selexipag (ACT-293987) in Pulmonary Arterial HypertensionPHASE3 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01106014 · fetched Nov 12, 2026
- Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple SclerosisPHASE2 · COMPLETED · started Oct 1, 2009ClinicalTrials.gov NCT01006265 · fetched Nov 12, 2026
- Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial HypertensionPHASE3 · COMPLETED · started Oct 17, 2008ClinicalTrials.gov NCT00667823 · fetched Nov 12, 2026